Fibroepithelial lesions with cellular stroma (FELCS) 
A b s t r a c t

Fibroepithelial lesions with cellular stroma (FELCS) in breast core needle biopsy (CNB) specimens may result in either fibroadenoma or phyllodes tumor at excision. We evaluated histologic features, proliferation indices (by Ki-67 and topoisomerase II α immunostaining) and p53 expression in 29 cases of FELCS in CNB specimens and correlated these with excision findings in a blinded manner. On excision, 16 patients had fibroadenomas and 12 had phyllodes tumors. All CNB specimens with mildly increased stromal cellularity were fibroadenomas on excision (n = 4), and all with markedly cellular stroma were phyllodes tumors (n = 4). Among CNB specimens with moderate cellularity (12 fibroadenomas and 8 phyllodes tumors), only stromal mitoses were discriminatory histologically. Stromal proliferation indices were significantly higher in CNB that were phyllodes tumors vs fibroadenomas. Assessment of stromal cellularity, mitoses, and proliferation indices might help determine the probability of phyllodes tumor occurring and guide management of these cases.
Fibroadenomas usually can be diagnosed readily in breast core needle biopsy (CNB) specimens based on classic histologic features. Therefore, these lesions can be managed safely by observation alone, provided that the imaging studies are concordant with that diagnosis. In contrast, the differential diagnosis of fibroepithelial lesions with cellular stroma (FELCS) in CNB specimens ranges from fibroadenoma to phyllodes tumor. Consequently, surgical excision is recommended for complete evaluation of these lesions. 1 Only a few studies exist that describe the surgical outcome of cellular fibroepithelial lesions when encountered in CNB specimens, with a substantial proportion of cases identified as phyllodes tumors at excision. [2] [3] [4] [5] All studies have had small case numbers and have provided limited pathologic details of the CNB or excision specimens, mostly from review of pathology reports rather than direct examination of histologic slides. [2] [3] [4] [5] Identification of pathologic features of FELCS in CNB specimens that are predictive of surgical outcome could assist in the management of these problematic cases.
In addition to histologic parameters, certain biologic markers are of potential interest in this context. For example, expression of the proliferation marker Ki-67 has been reported to vary among histologic categories of phyllodes tumor. [6] [7] [8] [9] In addition, significant differences in Ki-67 labeling indices have been reported between benign phyllodes tumors and fibroadenomas. 6 Another marker of cell proliferation, DNA topoisomerase II α (topo II), [10] [11] [12] is an enzyme that breaks and rejoins DNA strands 13 and is the molecular target for several chemotherapeutic drugs (eg, anthracyclines). [14] [15] [16] Topo II expression has been shown to correlate well with Ki-67 expression by immunohistochemical analysis, 12,17 particularly in breast tumors. 12 Mutations of the p53 gene also have been described in phyllodes tumors, 8 and recent studies have reported the potential usefulness of p53 immunostaining in the categorization of phyllodes tumors 9, [18] [19] [20] [21] [22] and in their distinction from fibroadenoma. 19 In the present study, we analyzed the pathologic features of a series of cases of FELCS in CNB specimens, all of which had surgical excision follow-up as part of their routine clinical care. All histologic parameters evaluated had been reported to be of potential use in the pathologic categorization of phyllodes tumors, prediction of clinical outcome, and/or distinction from fibroadenoma. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] In addition, CNB specimens were immunostained for the proliferation markers Ki-67 and topo II and for p53 protein. CNB and imaging findings then were correlated with excision results with a view to elucidating features useful in predicting the probability of phyllodes tumor occurring rather than fibroadenoma.
Materials and Methods
Study Design
The study population consisted of 29 patients who had a breast CNB specimen containing a FELCS that was followed by surgical excision of the lesion as part of the routine care. Cases were accessioned in the Virginia Mason Medical Center (VMMC) Pathology Department (Seattle, WA) between July 1, 1997 and December 31, 2003 , and in the University of California, San Francisco (UCSF) Department of Pathology between January 1, 1996, and June 30, 2003. These 29 cases represented 0.45% of all breast core biopsies (6,490) performed at VMMC (5,285) and UCSF (1, 205) during the study period. Cases were identified retrospectively by reviewing pathology reports of core biopsies in which the original diagnosis suggested a fibroepithelial lesion with increased stromal cellularity (with diagnostic terms including cellular fibroadenoma, fibroadenoma with cellular stroma, fibroepithelial lesion with cellular stroma, phyllodes tumor, or cystosarcoma phyllodes).
CNB slides of potential cases were initially reviewed, and only fibroepithelial lesions with stromal cellularity at least twice that of normal perilobular stroma were included. Overtly high-grade malignant spindle cell lesions (ie, in which the differential diagnosis included high-grade sarcoma or high-grade metaplastic carcinoma) were excluded from the analysis. All patients underwent surgical excision follow-up as part of their routine clinical care in accordance with CNB practice guidelines at VMMC and UCSF. The resultant 29 cases meeting the above criteria were studied. For each case, 4 H&E-stained levels per tissue block were reviewed, with a median number of 1 tissue block per case (range, 1-2). All H&E-stained slides of each CNB specimen were reviewed by 4 pathologists (T.W.J., D.G.G., Y.-Y.C., and I.C.), and consensus was obtained regarding histologic features (as outlined subsequently). Slides of the corresponding surgical excision specimens were reviewed simultaneously by 2 pathologists (T.W.J. and D.E.B.). Immunohistochemical analysis for p53, Ki-67, and topo II was performed as described subsequently on sections cut from 1 representative paraffin block of each CNB specimen. CNB specimen histologic features, CNB immunostains, excision specimen histologic features, and imaging studies were reviewed in a blinded manner, and the results were compared.
Biopsy Methods and Imaging
Core biopsies were performed under ultrasound guidance in 21 cases with 14-gauge Bard Core Disposable Needles (C.R. Bard, Covington, GA; 2-6 passes). Four core biopsies were guided by stereotactic mammography, all vacuum assisted (Mammotome needle, Ethicon Endo-Surgery, Cincinnati, OH). (Two were 11 gauge with 12 cores, and 2 were 14 gauge with 6 cores.) Four patients underwent core biopsy for palpable masses without radiographic guidance. All pertinent prebiopsy imaging studies were reviewed by 1 radiologist from each institution (B.H. at VMMC and D.W. at UCSF), and their findings were documented without knowledge of the CNB or excision pathology diagnoses. Imaging features evaluated included lesion size, relative circumscription (margin), level of suspicion according to the Breast Imaging Reporting and Data Systems (categorized on a scale of 0 to 6 as follows: 0, need additional imaging studies; 1, negative; 2, benign finding(s); 3, probably benign finding, short-interval follow-up suggested; 4, suspicious abnormality, biopsy should be considered; 5, highly suggestive of malignancy; and 6, known biopsy-proven malignancy). 34 Cases also were evaluated for concordance between imaging and biopsy, ie, whether the pathology on the CNB specimen was representative of the image-targeted lesion.
Histologic Examination
CNB Specimens
CNB slides were analyzed for the following histologic features:
1. Stromal cellularity was categorized qualitatively as mildly, moderately, or markedly increased. The most cellular area of the CNB slide was assessed for cellularity. Mildly increased stromal cellularity was defined as being approximately twice the cellularity of that of normal perilobular stroma, with none or rare stromal nuclei appearing to touch. Markedly increased stromal cellularity was characterized by stromal cells that were in close contiguity, resulting in areas of confluence with many stromal cell nuclei appearing to touch. 3. Mitotic count: Stromal cell mitotic figures were counted in the most mitotically active areas and expressed per 10 high-power fields (HPF; ×400). 4. The relative proportion of stroma to epithelium was estimated semiquantitatively as the overall relative percentage of stroma compared with epithelium present in at least 3 representative low-power fields (×40). 5. Stromal overgrowth was defined as the presence of stroma without epithelium in any low-power field (×40). 24 characterized by the projection of cellular stroma into clefts of cystic spaces. 11. Multinucleated stromal giant cells.
None of the core biopsy specimens contained heterologous elements (eg, cartilage or bone), stromal cell apoptosis, or necrosis.
Excision Specimen
Lesions were classified as fibroadenoma or phyllodes tumor. To be considered a phyllodes tumor, a fibroepithelial lesion was required at minimum to exhibit an enhanced intracanalicular growth pattern with leaf-like projections and associated cellular stroma. Phyllodes tumors were further categorized as benign, borderline (also termed low-grade malignant), or malignant by using a combination of histologic features (including degree of stromal cellularity, stromal cell pleomorphism, mitoses, tumor margins, and stromal overgrowth) according to published criteria (including the most recent 2003 World Health Organization classification of tumors). 20, 25, 30, 32, 33 The presence of heterologous sarcomatous elements (eg, liposarcoma, chondrosarcoma, osteosarcoma, and rhabdomyosarcoma) alone qualified a phyllodes tumor as malignant. 23, 25, 28, 29, 37 
Immunohistochemical Techniques
For each CNB case, 4-µm tissue sections were cut from 1 paraffin block and mounted on charged slides. Sections were A B C ❚Image 2❚ Fibroepithelial lesion with cellular stroma in a core needle biopsy (CNB) specimen with mildly increased stromal cellularity. At scanning power (A, H&E, ×40), the cellularity appears increased compared with that usually found in a fibroadenoma by CNB. At intermediate (B, H&E, ×100) and higher power (C, H&E, ×200), the stroma appears to be approximately twice as cellular as normal perilobular stroma with stromal nuclei rarely appearing to touch.
deparaffinized in xylene and rehydrated through graded alcohols to distilled water and immunostained for Ki-67, topo II, and p53 as follows:
Ki-67 Immunostaining
The slides were subjected to heat-induced epitope retrieval by immersing them in 0.01 mol/L of citrate buffer (pH 6.0) preheated to more than 90°C and then heated in a vegetable steamer (Black and Decker, Hampstead, MD) for 40 minutes, followed by a 20-minute cooldown period at room temperature. Slides then were incubated with the primary monoclonal antibody to Ki-67 antigen (clone Ki-S5, dilution 1:500; DAKO, Carpinteria, CA) on a DAKO Autostainer (DAKO) for 30 minutes at room temperature. Antibody was localized using the DAKO EnVision+ System with 3-3'-diaminobenzidine as the chromogen (DAKO) according to the manufacturer's instructions using the DAKO Autostainer and counterstained with hematoxylin. The Ki-67 index was defined as the percentage of cells that showed a positive nuclear stain. At least 250 stromal cells were counted for this analysis, and all Ki-67 indices were determined by 1 observer (T.W.J.).
Topo II Immunostaining
Immunostaining for topo II was performed and interpreted as previously described. 11 Briefly, tissue sections were subjected to heat-induced antigen retrieval by immersing them in 0.01 mol/L of citrate buffer (pH 6.0) and then heating them in a pressure cooker for 4 minutes, followed by a 26-minute cooldown period within the pressure cooker. The primary monoclonal antibody specific to topo II was used at a 1:1,000 dilution, and automated immunohistochemical staining was performed with the Nexes instrument (Ventana, Tucson, AZ) according to the manufacturer's instructions. The chromogen was 3-3'-diaminobenzidine. The topo II index was defined as A B C ❚Image 3❚ Fibroepithelial lesion with cellular stroma in a core needle biopsy specimen with moderately increased stromal cellularity. At low power (A, H&E, ×40), the stromal cellularity appears increased, with that in the right third of the field most cellular. Intermediate (B, H&E, ×100) and higher power (C, H&E, ×200) views of this area reveal the stroma to be moderately cellular with occasional stromal nuclei appearing to touch.
A B C ❚Image 4❚ Stromal cell nuclear atypia of fibroepithelial lesions with cellular stroma in core needle biopsy specimens. A, Grade 1 nuclei, which are similar in size and uniform appearance to stromal cell nuclei in normal perilobular stroma with absent or inconspicuous nuclei (H&E, ×400). B, Grade 2 nuclei with moderate increase in size and variability (H&E, ×400). C, Grade 3 nuclei with marked variability in size and shape with irregular nuclear membranes (H&E, ×400).
❚Image 5❚ Fibroepithelial lesion with cellular stroma in a core needle biopsy specimen with an infiltrative edge, demonstrating irregular projection of lesional stroma among surrounding adipose tissue (H&E, ×100).
❚Image 6❚ Core needle biopsy specimen of a fibroepithelial lesion with cellular stroma with increased stromal cellularity adjacent to the epithelium (H&E, ×100).
the percentage of cells that showed a positive nuclear stain. At least 500 stromal cells were counted for this analysis, and all topo II indices were determined by 1 observer (J.A.H.).
p53 Immunostaining
The method used for p53 immunostaining was essentially the same as that for Ki-67, with the exception of heatinduced epitope retrieval, which was for 20 minutes. The primary monoclonal antibody to p53 (clone DO-7, DAKO) was used at a 1:75 dilution. p53 staining was considered positive when more than 5% of the stromal cells showed distinct nuclear staining. All scoring was performed simultaneously by 2 observers (T.W.J. and D.G.G.).
For all 3 antigens, positive control samples were included in each staining run and consisted of freshly cut cases known to express the antigens of interest.
Statistical Methods
Statistical significance was set at a P value of less than .05. Data were analyzed by the Mann-Whitney rank sum test, Fisher exact test, and Spearman rank order correlation as appropriate. Computations were performed with SigmaStat for Windows software (version 2.03, SPSS, Chicago, IL).
Results
Patient and Imaging Data
The median age of patients with FELCS in CNB specimens was 47 years (range, 13-84 years). Patients with fibroadenoma at excision had a median age of 42 years (range, 13-70 years), and those with phyllodes tumor at excision had a median age of 51.5 years (range, 35-84 years) (P = .015).
When only cases with moderately increased stromal cellularity in CNB specimens were compared (see "Histologic Features of FELCS in CNB Specimens"), the age of patients with fibroadenoma on excision (median, 41 years; range, 13-70 years) did not differ significantly from that of patients with phyllodes tumor on excision (median, 50 years; range, 35-55 years) (P = .076).
Imaging studies were available for review in 27 of 28 cases (1 case of fibroadenoma biopsied by palpation had no radiologic studies) ❚Table 1❚. None of the imaging or biopsy parameters differed significantly between cases of fibroadenoma compared with cases of phyllodes tumor. Findings were similar when only cases with moderately increased stromal cellularity in CNB specimens were considered.
Surgical Excision Outcome
Of the 29 patients with FELCS in CNB specimens, 16 (55%) had a fibroadenoma at excision and 12 (41%) had a phyllodes tumor at excision ❚Image 7❚ and ❚Image 8❚. The stroma of 8 fibroadenoma cases was moderately cellular, but all cases had classic architectural features diagnostic of fibroadenoma. Among the phyllodes tumors, 5 were categorized as benign, 6 as borderline, and 1 as malignant (with liposarcomatous heterologous stromal elements, present in the excision specimen but not in the CNB specimen). Excision revealed that 1 FELCS case was a benign fibromatosis-like lesion with adjacent sclerosing adenosis, without features of a fibroepithelial lesion, and, therefore, it was not included in the subsequent analysis.
Histologic Features of FELCS in CNB Specimens
The histologic features of FELCS in CNB specimens in relation to surgical excision outcome are given in ❚Table 2❚. Only stromal cellularity, stromal cell atypia, stromal CNB, core needle biopsy; FELCS, fibroepithelial lesions with cellular stroma. * Imaging size (maximum single dimension), circumscription of the lesion on imaging, and BI-RAD score (Breast Imaging Reporting and Data System) were determined from review of imaging studies of 27 cases, but these parameters were not available for review in 1 fibroadenoma case biopsied by palpation. † Determined for image-guided biopsies (fibroadenoma, n = 15; phyllodes tumor, n = 12). Biopsy-imaging correlation: determination of whether the pathologic findings for the core biopsy specimen accounted for the lesion targeted on imaging (ie, a mass-forming lesion). ‡ All ultrasound guided biopsies were by 14-gauge automated gun; stereotactic biopsies were by vacuum assisted device (11 or 14 gauge); palpation-guided biopsies were with an automated gun (16 or 18 gauge).
mitoses, and the proportion of stroma to epithelium were significantly different among FELCS in CNB specimens that were fibroadenoma compared with those that were phyllodes tumors. None of the fibroadenoma cases had markedly increased stromal cellularity in CNB specimens, and none of the phyllodes tumor cases had mildly increased cellularity in CNB specimens. In contrast, cases with moderately increased stromal cellularity in CNB specimens were either fibroadenoma or phyllodes tumor at excision ❚Figure 1❚. Owing to this absolute segregation of cases by 1 parameter (mildly or markedly increased stromal cellularity) combined with our relatively small study sample, formal multivariate statistical analysis was not feasible. Therefore, separate statistical analysis was performed on the subset of cases with moderately increased stromal cellularity in CNB specimens ❚Table 3❚.
Among these cases, only the presence of stromal cell mitoses in CNB specimens remained significantly different between cases that were fibroadenoma at excision and those that were phyllodes tumor. However, the CNB mitotic counts overlapped between the 2 groups, with 1 or 2/10 HPF for the 2 fibroadenoma cases and a range of 1 to 6/10 HPF for the phyllodes tumor cases. Among the 6 phyllodes tumor cases with moderate cellularity in CNB specimens, 1 case had 1
A B A B
❚Image 7❚ A, Core needle biopsy specimen of a fibroepithelial lesion with cellular stroma with moderately increased stromal cellularity (H&E, ×40). B, The corresponding excision specimen demonstrates a fibroadenoma (cellular) (H&E, ×20).
❚Image 8❚ A, Core needle biopsy specimen of a fibroepithelial lesion with cellular stroma with moderately increased stromal cellularity (H&E, ×40) . B, The corresponding excision specimen demonstrated a phyllodes tumor (benign) (H&E, ×20).
mitosis per 10 HPF, 3 had 2/10 HPF, and 2 had 6/10 HPF. Of note, none of the cases of FELCS in CNB specimens with mildly increased stromal cellularity had stromal mitoses.
Immunohistochemical Results
Sufficient tissue was available for immunohistochemical studies in 24 (86%) of 28 CNB cases, 15 of which were fibroadenomas at excision and 9 of which were phyllodes tumors. Markers of stromal cell proliferation, Ki-67 index and topo II index, were correlated significantly (r = 0.815; P = 0). The Ki-67 and topo II indices were significantly higher in FELCS in CNB specimens that were phyllodes tumors compared with those that were fibroadenomas ❚Table 4❚. The results remained significant in the subset analysis of cases with moderately increased stromal cellularity ❚Table 5❚. However, the ranges for the Ki-67 and topo II indices overlapped. Of 9 cases in the phyllodes tumor group, 3 had a Ki-67 index of 4.4% or less (the upper end of the range for fibroadenomas), and all 15 fibroadenoma cases were more than zero (the lower end of the phyllodes tumor range). Similarly, the topo II index was 10% or less in 5 of 9 phyllodes tumor cases (the upper end of the fibroadenoma range) and 1.2% or more in 11 of 15 fibroadenomas (the lower end of the phyllodes tumor range). Of note, none of the cases of mildly increased stromal cellularity in CNB specimens had a Ki-67 index of more than 3.2% or a topo II index of more than 3.4%. p53 immunostaining did not discriminate between FELCS in CNB specimens (Tables 4 and 5 ). CNB, core needle biopsy. * Results are expressed as the number of cases with the histologic feature present (percentage of total cases) or number of cases with the histologic feature present/total number of cases (percentage of total cases) unless otherwise indicated. Some percentages do not total 100 because of rounding. For more information on the histologic features, see the text. † Among phyllodes tumors with moderately increased stromal cellularity in CNB specimens, 4 were benign and 4 were borderline at excision. ‡ Among phyllodes tumors with markedly increased stromal cellularity in CNB specimens, 1 was benign, 2 were borderline, and 1 was malignant at excision. § The infiltrative edge was evaluable in 14 cases that were fibroadenoma at excision and 8 that were phyllodes tumor. 
Discussion
To our knowledge, this is the largest series of cases of FELCS in CNB specimens with excision follow-up and review of CNB and excision slides. The few previous studies that exist had small patient numbers and relied mainly on review of pathology reports rather than slide review per se. Dershaw et al 2 reported that 3 of 7 cases diagnosed as "fibroadenoma versus phyllodes" in CNB specimens resulted in phyllodes tumor (benign) at surgical excision. Meyer et al 3 found that among 9 mass lesions diagnosed as "probable fibroadenoma with cellular stroma, rule out phyllodes" in CNB specimens, 2 were identified as phyllodes tumors at excision. Ioffe et al 4 described 1 case of "cellular fibroadenoma vs. phyllodes tumor" in a CNB specimen that was identified as a cellular fibroadenoma on surgical excision. A recent study, based on review of pathology reports, found 4 phyllodes tumors at excision among 9 cases that were diagnosed from CNB specimens as "equivocal" fibroepithelial lesions. 5 A further 23 cases were diagnosed as "favoring fibroadenoma" in (13) .400
* Results are expressed as the number of cases with the histologic feature present (percentage of total cases) or number of cases with the histologic feature present/total number of cases (percentage of total cases) unless otherwise indicated. Some percentages do not total 100 because of rounding. For more information on the histologic features, see the text. † The infiltrative edge was evaluable in 10 cases that were fibroadenoma at excision and 7 that were phyllodes tumor.
CNB specimens, and 25 were diagnosed as "favoring phyllodes tumor" in CNB specimens, with phyllodes tumor identified at excision in 19 and 2 cases, respectively. These diagnostic categories for fibroepithelial lesions in CNB specimens would have been clinically more useful and probably more reproducible had specific histologic criteria been developed, rather than relying on the diagnosing pathologist's opinion per se.
Instead of assigning separate presumptive diagnostic categories to cases of FELCS in CNB specimens, we evaluated several histologic features that had been reported to be of potential use in the histologic categorization, prognosis, or differential diagnosis of phyllodes tumors. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] The initial univariate statistical analysis revealed that 4 stromal features in CNB specimens (ie, cellularity, nuclear atypia, mitoses, amount relative to epithelium) differed significantly between cases that were fibroadenoma at excision compared with those that were phyllodes tumor. However, only cases that had mildly or markedly increased stromal cellularity in CNB specimens were absolutely predictive of fibroadenoma or phyllodes tumor, respectively.
Among the subset of cases with moderate stromal cellularity in the CNB specimens, the presence of stromal mitoses remained the single histologic feature significantly different between the phyllodes tumor and fibroadenoma groups. Although the number of phyllodes cases with stromal mitoses in CNB specimens was significantly higher compared with the number of fibroadenoma cases with mitoses, the range of mitotic counts overlapped: 2 of the fibroadenoma cases had 1 or 2 mitoses per 10 HPF, as did 4 of the phyllodes tumor cases. Of note, the presence of mitotic figures per se does not preclude a diagnosis of fibroadenoma. Provided that the mitoses are in the context of appropriate histologic features of a fibroadenoma, a mitotic rate of up to 2/10 HPF is acceptable. 38 Both cases in the fibroadenoma group with mitoses in CNB specimens exhibited the classic architectural pattern of fibroadenoma in the excision specimen, without nuclear atypia or significant overall cellularity.
CNB immunostaining results for the proliferation markers Ki-67 and topo II paralleled our observations of stromal mitoses. Both indices were significantly higher in cases that were identified as phyllodes tumors at excision compared with those that were fibroadenoma, on univariate and subset analyses. However, as with mitoses, the ranges overlapped.
In addition to these findings, our study highlights the difficulty of extrapolating histologic criteria that are useful for excision specimens to the context of CNB specimens. For example, we found that a leaf-like pattern, an invasive lesional border, or stromal overgrowth (all useful parameters for diagnosing phyllodes tumors in surgical excision specimens) were unhelpful for discriminating between FELCS in CNB specimens. Furthermore, some phyllodes tumors might have less cellular or "fibroadenoma-like" areas 31, 32 and would, therefore, be subject to sampling issues of the CNB technique. Although consensus was reached among 4 study pathologists for all CNB histologic parameters, assessment of stromal cellularity is potentially an area open to interobserver variability, particularly at the mild and moderate thresholds.
Imaging findings were not helpful in discriminating between lesions that were fibroadenomas and those that were phyllodes tumors, in keeping with the findings of previous studies that have demonstrated difficulty in this regard. [39] [40] [41] Assessment of other imaging variables such as velocity of lesion growth might be useful 42 ; however, this was not feasible in our study owing to lack of serial imaging studies in most cases. The role of newer breast imaging modalities such as magnetic resonance 43, 44 and proton magnetic resonance spectroscopy 45 also needs further evaluation in the context of these lesions.
Current management of patients with FELCS in CNB specimens consists of surgical excision of the lesion. However, optimal surgical management differs for phyllodes tumors compared with fibroadenomas. Adequate surgical excision of phyllodes tumors with negative margins is required to avoid local recurrence. 20, 30, [46] [47] [48] [49] [50] In contrast, fibroadenomas are effectively treated by lesional enucleation without concern for surgical margins. Treating all patients who have FELCS in CNB specimens with the same surgical procedure might, depending on the quantity of tissue removed, result in excessive surgery for patients with fibroadenomas or insufficient surgery for patients with phyllodes tumors. In addition, achieving negative margins at the time of primary excision for phyllodes tumor is preferable to reexcision with removal of more tissue and a less favorable cosmetic result.
Our findings suggest that assessment of stromal cellularity, mitoses, and proliferation indices in CNB specimens is potentially useful for assessing the probability of a FELCS being a fibroadenoma or phyllodes tumor and, therefore, guiding management of these lesions. First, FELCS in CNB specimens that have markedly increased stromal cellularity are most likely to be phyllodes tumors and should be managed as such. Second, FELCS in CNB specimens with moderately increased stromal cellularity, stromal mitoses (particularly if >2/10 HPF), and elevated proliferation marker indices (Ki-67 or topo II) have a high probability of being phyllodes tumors. Patients with these tumors would benefit from surgical excision more appropriate for phyllodes tumor (ie, a wider initial excision to achieve negative margins). Third, FELCS in CNB specimens with moderately increased stromal cellularity, no stromal mitoses, and low proliferation marker indices might be fibroadenomas or phyllodes tumors. These lesions should be excised, but initially could be shelled out surgically, with further treatment dependent on the final pathology findings. Last, our findings raise the possibility that surgical excision might be unnecessary for patients whose CNB specimens show FELCS with mildly increased stromal cellularity, especially those with no mitoses and low proliferation indices. Nevertheless, based on inherent variability in CNB sampling and the subjective nature of the assessment of degree of cellularity, we believe that excision of even these lesions remains prudent until further outcome studies are completed.
